ALTERITY THERAPEUTICS LTD - Form 3 Filing

This filing is an initial statement of beneficial ownership of securities filed by Ann Michelle Cunningham, a director at ALTERITY THERAPEUTICS LTD. The report indicates that Ms. Cunningham has no securities owned as of the period of report, April 17, 2026. The filing is made in accordance with SEC regulations for reporting changes in ownership by company insiders. The document is a Form 3, which is used to report initial ownership.